2-(16-acetyloxy-3,11-dihydroxy-4,8,10,14- tetramethyl- 2,3,4, 5,6,7, 9,11,12, 13,15,16- dodecahydro- 1H-cyclopenta [a]phenanthren-17-ylidene) -6-methyl- hept-5-enoic acid
|
|
Protein binding: 97%
Metabolism: Hepatic, to multiple metabolites
Half-life elimination: 5-6 hours
Time to peak, serum: Oral: 2-4 hours
Excretion: Feces (~100%, via bile)
|
